Do FDA-approved medical studies count as significant impact?

They can, yes. In the EB-2 NIW, a medical study that has received FDA approval tends to serve as a strong indicator of innovation and clinical relevance, because it signals that your work has reached a stage of validation with real potential impact on health. Even so, it is one element among many, not a stand-alone proof.

What the EB-2 NIW evaluates is how your work benefits the national interest. An FDA approval carries more weight when you place it within a body of evidence that tells a coherent story of impact, showing the reach and importance of the outcome beyond the approval itself.

• Explain what the approval represents in terms of concrete advancement.
• Pair it with other evidence, such as publications and recognitions.
• Connect the result to the broader benefit it generates.

Each case is reviewed individually by the USCIS, so it is worth building a consistent portfolio and, if it makes sense, reviewing your evidence strategy with a specialist before filing.

About the author

Victoria Harper

Editor-in-Chief

Meet the author

As a journalist and lead editor at Visto n’ Visa, Victoria helps ensure that immigration topics are covered in a clear, trustworthy, and easy-to-understand way. Her focus is on delivering useful, human, and relevant content for people exploring new paths abroad.